Evidence map›Paper›PMID 30858698›Full record

ArticleDrug design, development and therapy2019

Synthesis of budesonide conjugates and their anti-inflammatory effects: a preliminary study.

Yan Yan, Pengchong Wang, Ruiying Li, Ying Sun, Rui Zhang, Chuanchuan Huo, Jianfeng Xing, Yalin Dong

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Approaches Towards Better Immunosuppressive Agents.Current topics in medicinal chemistry · 2024
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yan YanDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, dongyalin@mail.xjtu.edu.cn.
Pengchong WangDepartment of Pharmaceutics, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China, xajdxjf@mail.xjtu.edu.cn.
Ruiying LiDepartment of Clinical Medicine, College of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Ying SunDepartment of Pharmaceutics, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China, xajdxjf@mail.xjtu.edu.cn.
Rui ZhangDepartment of Pharmaceutics, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China, xajdxjf@mail.xjtu.edu.cn.
Chuanchuan HuoDepartment of Pharmaceutics, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China, xajdxjf@mail.xjtu.edu.cn.
Jianfeng XingDepartment of Pharmaceutics, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China, xajdxjf@mail.xjtu.edu.cn.
Yalin DongDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, dongyalin@mail.xjtu.edu.cn.
First Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBudesonide (Bud) is a nonhalogenated glucocorticoid with high anti-inflammatory potency and low systemic side effects. However, the poor water solubility of Bud affects its dissolution and release behavior, thus influencing its anti-inflammatory effect. This study was aimed at synthesizing and evaluating novel conjugates of Bud, hoping to increase the anti-inflammatory activity of Bud by improving its water solubility. MATERIALS AND

methodsSeven novel Bud conjugates (

resultsAs compared to Bud, the equilibrium solubility of

conclusionThe amino acid ester compounds budesonide-21-glycine ester (

Indexed as

A549 CellsAnimalsAnti-Inflammatory Agents, Non-SteroidalBudesonideCell SurvivalEar DiseasesEdemaHumansInterleukin-6Interleukin-6 InhibitorsMaleMiceMice, Inbred StrainsMolecular StructureRatsRats, Sprague-DawleyAnti-Inflammatory Agents, Non-SteroidalBudesonideInterleukin-6Interleukin-6 InhibitorsXylenesanti-inflammatory effectbudesonideequilibrium solubilityglucocorticoidhydrolysis behavior

Identifiers

PMID30858698
PMCPMC6387599
OpenAlexW2911679168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.